Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2011-5-9
pubmed:abstractText
Prognostic factors can guide the physician in selecting the optimal treatment for an individual patient. This study investigates the prognostic value of erythropoietin (EPO) and EPO receptor (EPO-R) expression of tumor cells for locoregional control and survival in non-small-cell lung cancer (NSCLC) patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1879-355X
pubmed:author
pubmed:copyrightInfo
Copyright © 2011 Elsevier Inc. All rights reserved.
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
80
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
499-505
pubmed:meshHeading
pubmed-meshheading:20646855-Age Factors, pubmed-meshheading:20646855-Aged, pubmed-meshheading:20646855-Analysis of Variance, pubmed-meshheading:20646855-Carcinoma, Non-Small-Cell Lung, pubmed-meshheading:20646855-Erythropoietin, pubmed-meshheading:20646855-Female, pubmed-meshheading:20646855-Hemoglobin A, pubmed-meshheading:20646855-Humans, pubmed-meshheading:20646855-Karnofsky Performance Status, pubmed-meshheading:20646855-Lung Neoplasms, pubmed-meshheading:20646855-Male, pubmed-meshheading:20646855-Middle Aged, pubmed-meshheading:20646855-Neoplasm Proteins, pubmed-meshheading:20646855-Neoplasm Staging, pubmed-meshheading:20646855-Prognosis, pubmed-meshheading:20646855-Radiotherapy, Conformal, pubmed-meshheading:20646855-Receptors, Erythropoietin, pubmed-meshheading:20646855-Sex Factors, pubmed-meshheading:20646855-Smoking
pubmed:year
2011
pubmed:articleTitle
Prognostic impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage II/III non-small-cell lung cancer.
pubmed:affiliation
Department of Radiation Oncology, University of Lubeck, Germany. Rades.Dirk@gmx.net
pubmed:publicationType
Journal Article